Systematic review of topical capsaicin in the treatment of pruritus

International Journal of Dermatology

Volumn 49, Issue 8, 2010, Pages 858-865

  Gooding, Sylvia M D ^a   Canter, Peter H ^a   Coelho, Helen F ^a   Boddy, Kate ^a   Ernst, Edzard ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; PLACEBO;

ANUS PRURITUS; CLINICAL TRIAL; CREAM; DISEASE SEVERITY; DRUG EFFICACY; HEMODIALYSIS; HUMAN; OINTMENT; OUTCOME ASSESSMENT; PRURITUS; REVIEW; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE;

ANTIPRURITICS; CAPSAICIN; HUMANS; PRURITUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77954924312     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04537.x     Document Type: Review

References (38)

1. Murray CS. New concepts in the measurement of itch. Dermatol Pract 2007, 15:22-24.
2. Yosipovitch G, Hundley JL. Practical guidelines for the relief of itch. Dermatol Nurs 2004, 16:325-329.
3. Bernstein JE. Capsaicin the treatment of dermatologic disease. Cutis 1987, 39:352-353.
4. O'Connor TM, O'Connell J, O'Brien DI. The role of substance P in inflammatory disease. J Cell Physiol 2004, 201:167-180.
5. Payan P. Neuropeptides and inflammation. The role of substance P. Annu Rev Med 1989, 40:341-352.
6. Naukkarinen A, Nickoloff BJ, Farber EM. Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 1989, 92:126-129.
7. Toyoda M, Nakamura M, Makino T. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002, 147:71-79.
8. Bernstein JE, Parish LC, Rapaport M. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 1986, 15:504-507.
9. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin: a meta-analysis. Eur J Clin Pharmacol 1994, 46:517-522.
10. Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996, 17:1-12.
11. Imai S. Effect of topically applied capsaicin on the cutaneous reaction to histamine. Arch Dermatol Res 1991, 283:414-416.
12. Simone DA, Ochoa J. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 1991, 47:285-294.
13. Weisshaar E, Dunker N, Gollnick H. Topical capsaicin therapy in humans with hemodialysis-related pruritus. Neurosci Lett 2003, 345:192-194.
14. Weisshaar E, Ziethen B, Gollnick H. Lack of efficacy of topical capsaicin in serotonin-induced itch. Skin Pharmacol Appl Skin Physiol 2000, 13:1-8.
15. Gossel TA. Capsaicin therapy for diabetic neuropathy. U.S. Pharmacist 1993, 18:20-24.
16. Burrows NP, Norris PG. Treatment of PUVA-induced skin pain with capsaicin. Br J Dermatol 1994, 131:584-585.
17. Lysy J, Sistiery IM, Israelit Y. Topical capsaicin cream was effective for chronic idiopathic intractable pruritis ani. EBM 2004, 9.
18. Drugs for skin. Geneesmiddelenbulletin 1994, 28:35-38.
19. A novel and effective treatment for pruritus ani. S Afr Med J 2004, 94:912.
20. Gutknecht DR. Topical capsaicin cream was effective for chronic idiopathic intractable pruritis ani. EBM 2004, 9:86.
21. Cappugi P, Isolani D, Lorusso B. Topical capsaicin for treatment of postherpetic itch and pain. G Ital di Dermatol Venereol 1993, 128:611-614.
22. Chrubasik S, Meyer-Buchtela E, Pollak S. Therapy of pain with capsaicin-containing topical preparations. Z Phytother 2002, 23:216-218.
23. Ellis CN, Berberian B, Sulica VI. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993, 29:438-442.
24. Fileccia P. Topical capsaicin in the treatment of pruritus in hemodialysis patients. Chron Dermatol 1992, 2:618-619.
25. Folster-Holst R, Brasch J. Effect of topically applied capsaicin on pruritus in patients with atopic dermatitis. J Dermatol Treat 1996, 7:13-15.
26. Gronroos M, Reunala T, Kartamaa M. Altered skin sensitivity in chronic itch: Role of peripheral and central mechanisms. Neurosci Lett 1997, 228:199-202.
27. Lamey B. Neurogenic pruritus: clinical diagnosis, pathogeny and therapeutic proposition. About 22 personal cases. Nouvelles Dermatol 2007, 26:509-510.
28. Lotti T, Teofoli P, Tsampau D. Treatment of aquagenic pruritus with topical capsaicin cream. J Am Acad Dermatol 1994, 30:232-235.
29. Ständer S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001, 44:471-478.
30. Weisshaar E, Heyer G, Forster C. Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin. Arch Dermatol Res 1998, 290:306-311.
31. Xu MH, Chai JK, Lu JL. A preliminary report of therapeutic effects of topical capsaicin in postburn hypertrophic scar. Zhonghua Shao Shang Za Zhi 2003, 19(Suppl):8-10.
32. Breneman DL, Cardone JS, Blumsack RF. Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 1992, 26:91-94.
33. Cho YL, Liu HN, Huang TP. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 1997, 36:538-543.
34. Tarng DC, Cho YL, Liu HN. Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron 1996, 72:617-622.
35. Lysy J, Sistiery-Ittah M, Israelit Y. Topical capsaicin - a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut 2003, 52:1323-1326.
36. Wallengren J, Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 1995, 32:287-289.
37. Wallengren J. Brachioradial pruritus: a recurrent solar dermopathy. J Am Acad Dermatol 1998, 39:803-806.
38. Mason L, Moore RA, Derry S. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004, 328:991-994.